UW biotech spinout raises $5M to develop gene therapy system for muscular dystrophy by Charlotte Schubert on January 25, 2023January 25, 2023 at 9:46 pm The news: Myosana Therapeutics, a Seattle startup developing gene therapy technology, raised $5 million to develop an early-stage candidate treatment for Duchenne muscular dystrophy (DMD). Mysona says its experimental platform… Read More